The narrative shift has been from a storage supplier to an essential AI infrastructure player, providing high-performance flash memory for AI data centers amid global supply shortages. : The "Biotech Maverick". This is the top performer of 2026 so far, up nearly 400%.
Fueling its story is an aging population and a massive boom in GLP-1 drugs like Mounjaro and Zepbound. top 5 shares to buy
Its story is driven by the commercial launch of Anktiva, a drug that boosts the natural immune system to treat cancer, and successful expansions into international markets like Saudi Arabia and Europe. The narrative shift has been from a storage